Delivery Order SPE2DR25D2206-SPE2DR26F9DF0
- Not listed
- The Defense Logistics Agency awarded a $25,681.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT (avapritinib) 25 mg tablets in a 30-count package on November 26, 2025, with completion scheduled for December 18, 2025. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement valued through December 2026 that serves as the primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count quantity, with a ceiling value of $24,368.92 and a firm fixed-price structure. This delivery order is not set-aside and represents a competitive award under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion master contract vehicle valued through December 2026 that enables...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packages) with a ceiling value of $97,475.68. This firm fixed price delivery order, with an ultimate completion date of October 17, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of AYVAKIT 200 mg tablets (30-count units) with a ceiling value of $24,403.80. This firm fixed-price delivery order, with an ultimate completion date of November 6, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award utilized no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of AYVAKIT 300 mg tablets (30-count) with a ceiling value of $24,675.50. This firm fixed-price delivery order, which is expected to be completed by August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of AYVAKIT 25 MG tablets (30-count units) with a ceiling value of $24,368.92. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $25,681.09 firm fixed price delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count units) with a completion date of January 2, 2026. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical supplier within the federal medical procurement system. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count) under a firm fixed-price contract valued at $24,368.92, with an ultimate completion date of August 21, 2025. This non-competitive delivery order was issued on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through DLA's medical supply chain to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Ayvakit 25 mg tablets in a quantity of 30 units, with a ceiling value of $25,681.09 and firm fixed pricing. This competitive, non-set-aside delivery order is scheduled for completion by November 28, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child award issued under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT 25 mg tablets (30-count units) on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9DF0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,717.85 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 200 mg tablets in a 30-count configuration. This firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's comprehensive IDC with DLA valued at $999,999,999.00 through December 2026, which establishes the company as a prime vendor for global pharmaceutical support. The contract vehicle enables the company to supply a broad range of pharmaceutical products, specialty medications, and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. AYVAKIT, an oncology therapeutic agent, aligns with the company's portfolio of specialized medications delivered through DLA's Medical Supply Chain to support military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 11/24/25 |